Alentis Therapeutics
FranceEntry
2021
Hold
5yr
Status
Active
Who owns Alentis Therapeutics?
Alentis Therapeutics is a French Biotech company, currently owned by Novo Holdings since 2023 and Jeito Capital.
Hand-verified · updated 2026-09-30
Open JSON · CC-BY
Ownership history
2 ownership periods · co-invest detected
Active
Co-invest · 2 holders · 2021 · present
Jeito CapitalActive
2021 · present(5yr) · Jeito I · 2021 · VC
Novo HoldingsActive
2023 · present(3yr) · Novo Holdings Venture Investments · 1999 · VC
More from Jeito I
Other portfolio companies in the same fund.
Switzerland
Spain
Germany
USMore PE-backed in Biotech
Comparable biotech deals from other GPs.
Questions
Who owns Alentis Therapeutics?
Alentis Therapeutics is currently owned by Novo Holdings and Jeito Capital, through Jeito I, since 2023.
When did Novo Holdings and 1 other acquire Alentis Therapeutics?
Novo Holdings and 1 other acquired Alentis Therapeutics in 2023.
Who has owned Alentis Therapeutics over time?
Alentis Therapeutics has been through 2 private-equity ownership periods: Jeito Capital · via Jeito I · since 2021; Novo Holdings · via Novo Holdings Venture Investments · since 2023.
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue